Name and surname:
|
MUDr. Martin Schnierer, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
assistant professor | Clinic of Internal Medicine - Gastroenterology | 2010-ongoing |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
Specialisation in gastroenterology | Comenius University in Bratislava, Jessenius Faculty of Medicine Clinic of Internal Medicine - Gastroenterology | 2016 |
Specialisation in internal medicine | Comenius University in Bratislava, Jessenius Faculty of Medicine Clinic of Internal Medicine | 2019 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Internal Medicine Propedeutics | General medicine | I.+II. | General medicine |
Internal medicine | General medicine | I. and II. | General Medicine |
Internal Medicine Propedeutics | Dentistry | I. and II. | Dentistry, Dental Medicine |
Dentistry, | Internal medicine | I. and II. | Dentistry, Dental Medicine |
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study. In: Journal of Cardiovascular Pharmacology. - Roč. 70, č. 4 (2017), s. 263-266. - ISSN 0160-2446
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study. In: Journal of Cardiovascular Pharmacology. - Roč. 70, č. 4 (2017), s. 263-266. - ISSN 0160-2446
Bolek T., Samoš M., Škorňová I., Schnierer M., Lipták P., Bánovčin P., Urban L., Staško J., Kubisz P, Galajda P., Mokáň M.: Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference?
In: European journal of clinical pharmacology. - Roč. 75, č. 6 (2019), s. 875-877. - ISSN (print) 0031-6970
Škorňová I., Šimurda T., Staško J., Horváth D., Žolková J., Hollý P., Brunclíková M., Samoš M., Bolek T., Schnierer M., Slavík L., Kubisz P.: Use of Fibrinogen Determination Methods in Differential Diagnosis of Hypofibrinogenemia and Dysfibrinogenemia
In: Clinical laboratory. - Roč. 67, č. 4 (2021), s. 1028-1034 - ISSN 1433-6510
Lipták P., Schnierer M., Bánovčin P., Ďuriček M., Hyrdel R.: Idiopathic Pan-Colonic and Small-Intestine Varices In: Case Reports in Gastroenterology. - Roč. 12, č. 3 (2018), s. 757-764. - ISSN 1662-0631
Schnierer M., Samoš M., Bolek T., Škorňová I., Nosáková L., Bánovčin P., Galajdav P., Staško J., Kubisz P., Hyrdel R., Mokáň M., The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study. Journal of Cardiovascular Pharmacology. - Roč. 75, č. 4 (2020), s. 333-335. - ISSN 0160-2446
Lit.: 13 zázn.
In: Journal of Cardiovascular Pharmacology [elektronický dokument]. - Roč. 75, č. 4 (2020), s. 333-335 [print]. - ISSN (print) 0160-2446
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study. In: Journal of Cardiovascular Pharmacology. - Roč. 70, č. 4 (2017), s. 263-266. - ISSN 0160-2446. citácia/citation: [o1] 2020 Trani, A. - Benedetto, P. - Di Leo, F. - Baiano, A. - Esposito, A. - Menna, D. - Allegretti, A. - Cappiello, P. A. - Dell'Edera, D.: Journal of Pharmaceutical Health Care and Sciences, roč. 6, č. 1, 2020, čl. č. 17 - SCI ; SCOPUS
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study. In: Journal of Cardiovascular Pharmacology. - Roč. 70, č. 4 (2017), s. 263-266. - ISSN 0160-2446. citácia/citation: [o1] 2021 Polzin, A. - Dannenberg, L. - Thienel, M. - Orban, M. - Wolff, G. - Hohlfeld, T. - Zeus, T. - Kelm, M. - Petzold, T.: Thrombosis and Haemostasis, roč. 121, č. 2, 2021, s. 122-130 - SCI ; SCOPUS
Bolek T., Samoš M., Škorňová I., Schnierer M., Lipták P., Bánovčin P., Urban L., Staško J., Kubisz P, Galajda P., Mokáň M.: Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference?
In: European journal of clinical pharmacology. - Roč. 75, č. 6 (2019), s. 875-877. - ISSN (print) 0031-6970. citácia/citation: [o1] 2020 Coppiano, L. S. - May, D.: Side Effects of Drugs Annual, roč. 42, 2020, s. 361-375 - SCOPUS
Schnierer M., Samoš M., Bolek T., Škorňová I., Nosáková L., Bánovčin P., Galajdav P., Staško J., Kubisz P., Hyrdel R., Mokáň M., The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study. Journal of Cardiovascular Pharmacology. - Roč. 75, č. 4 (2020), s. 333-335. - ISSN 0160-2446
Lit.: 13 zázn.
In: Journal of Cardiovascular Pharmacology [elektronický dokument]. - Roč. 75, č. 4 (2020), s. 333-335 [print]. - ISSN (print) 0160-2446. citácia/citation: [o1] 2021 Stöllberger, C. - Finsterer, J.: Expert Review of Clinical Pharmacology, roč. 14, č. 5, 2021, s. 569-581 - SCI ; SCOPUS
Schnierer M., Samoš M., Bolek T., Škorňová I., Nosáková L., Bánovčin P., Galajdav P., Staško J., Kubisz P., Hyrdel R., Mokáň M., The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study. Journal of Cardiovascular Pharmacology. - Roč. 75, č. 4 (2020), s. 333-335. - ISSN 0160-2446, citácia/citation: [o1] 2021 Coppiano, L. S. - May, D.: ) Side Effects of Drugs Annual, č. 43, 2021, s. 415-429 - SCOPUS
In: Journal of Cardiovascular Pharmacology. - Roč. 75, č. 4 (2020), s. 333-335. - ISSN 0160-2446
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study. In: Journal of Cardiovascular Pharmacology. - Roč. 70, č. 4 (2017), s. 263-266. - ISSN 0160-2446. citácia/citation: [o1] 2020 Trani, A. - Benedetto, P. - Di Leo, F. - Baiano, A. - Esposito, A. - Menna, D. - Allegretti, A. - Cappiello, P. A. - Dell'Edera, D.: Journal of Pharmaceutical Health Care and Sciences, roč. 6, č. 1, 2020, čl. č. 17 - SCI ; SCOPUS
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study
Bánovčin P., Škorňová I., Samoš M., Schnierer M., Bolek T., Kovář F., Staško J., Kubisz P., Mokáň M. Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study. In: Journal of Cardiovascular Pharmacology. - Roč. 70, č. 4 (2017), s. 263-266. - ISSN 0160-2446. citácia/citation: [o1] 2021 Polzin, A. - Dannenberg, L. - Thienel, M. - Orban, M. - Wolff, G. - Hohlfeld, T. - Zeus, T. - Kelm, M. - Petzold, T.: Thrombosis and Haemostasis, roč. 121, č. 2, 2021, s. 122-130 - SCI ; SCOPUS
Bolek T., Samoš M., Škorňová I., Schnierer M., Lipták P., Bánovčin P., Urban L., Staško J., Kubisz P, Galajda P., Mokáň M.: Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference?
In: European journal of clinical pharmacology. - Roč. 75, č. 6 (2019), s. 875-877. - ISSN (print) 0031-6970. citácia/citation: [o1] 2020 Coppiano, L. S. - May, D.: Side Effects of Drugs Annual, roč. 42, 2020, s. 361-375 - SCOPUS
Schnierer M., Samoš M., Bolek T., Škorňová I., Nosáková L., Bánovčin P., Galajdav P., Staško J., Kubisz P., Hyrdel R., Mokáň M., The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study. Journal of Cardiovascular Pharmacology. - Roč. 75, č. 4 (2020), s. 333-335. - ISSN 0160-2446
Lit.: 13 zázn.
In: Journal of Cardiovascular Pharmacology [elektronický dokument]. - Roč. 75, č. 4 (2020), s. 333-335 [print]. - ISSN (print) 0160-2446. citácia/citation: [o1] 2021 Stöllberger, C. - Finsterer, J.: Expert Review of Clinical Pharmacology, roč. 14, č. 5, 2021, s. 569-581 - SCI ; SCOPUS
313011ASX4 – STU Výskum a vývoj telemedicínskeho systému na podporu monitorovania možného šírenia ochorenia COVID-19 s cieľom rozvoja analytických nástrojov slúžiacich na znižovanie rizika nákazy/Research and development of the telemedicine system solutions to support monitoring of potential spread of COVID-19 disease in order to develop analytic tools to decrease the risk of infection
313011ASY8 - Výskum a rozvoj telemedicínskych riešení na podporu boja proti pandémii vyvolanej ochorením COVID-19 a znižovaní jej negatívnych následkov monitorovaním zdravotného stavu ľudí za účelom eliminácie rizika nákazy u rizikových skupín obyvateľstva/Research and development of telemedicine solutions to support the fight against pandemic diseases induced Covid-19 and reducing its negative consequences by monitoring the health status of people in order to eliminate the risk of infection in at risk populations